PolyRemedy, Inc., manufactures robotic systems for the fabrication of nano material-based wound dressings at the point-of-care, allowing wound care clinicians to deliver customized wound care on-demand for each patient's unique wound.
Portola Pharmaceuticals, Inc. is a private biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutics for acute and chronic cardiovascular and vascular disease. They are conducting a Phase II clinical trial with their oral Factor Xa inhibitor for the prevention of deep vein thrombosis, and a Phase I clinical program with th...
More >>
Portola Pharmaceuticals, Inc. is a private biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutics for acute and chronic cardiovascular and vascular disease. They are conducting a Phase II clinical trial with their oral Factor Xa inhibitor for the prevention of deep vein thrombosis, and a Phase I clinical program with their direct-acting, oral and IV ADP receptor antagonist. These drug candidates could potentially advance patient care in the $14 billion anti-thrombotics market. Portola also has a robust drug discovery platform focusing on the platelet and signaling pathways that mediate thrombosis and inflammation.
<< Less
CaliSolar is engaged in the development and manufacturing of high efficiency solar cells using 100% UMG Si. The company is incorporated in the USA and conducts its production operations in both USA and Germany. CaliSolar has a development center, BerlinSolar GmbH, based in Berlin Germany and headquarters in Sunnyvale, CA. The company was founded in 2006 by Dr. Kamel O...
More >>
CaliSolar is engaged in the development and manufacturing of high efficiency solar cells using 100% UMG Si. The company is incorporated in the USA and conducts its production operations in both USA and Germany. CaliSolar has a development center, BerlinSolar GmbH, based in Berlin Germany and headquarters in Sunnyvale, CA. The company was founded in 2006 by Dr. Kamel Ounadjela, Dr. Fritz Kirscht and Dr. Eicke Weber.
<< Less
GreatPoint Energy, founded in 2004, is commercializing a new process to produce low cost substitute natural gas from coal. The company is developing an advanced catalytic gasification technology to convert low grade sub-bituminous and lignite coals to a high value pipeline grade gas. In addition to lower cost, GPE aims to provide a domestically sourced fuel gas with s...
More >>
GreatPoint Energy, founded in 2004, is commercializing a new process to produce low cost substitute natural gas from coal. The company is developing an advanced catalytic gasification technology to convert low grade sub-bituminous and lignite coals to a high value pipeline grade gas. In addition to lower cost, GPE aims to provide a domestically sourced fuel gas with substantially less price volatility than natural gas and a similarly clean environmental profile. The goal of the company is to build, own and operate gas production facilities and to sell substitute natural gas to distressed natural gas power plant operators and large industrial users.
<< Less
Coskata is a biology-based renewable energy company. Coskata's technology aims to enable the low-cost production of ethanol from a wide variety of input material including biomass, municipal solid waste and other carbonaceous material. Using microorganisms and patented bioreactor designs, Coskata claims they will produce ethanol for under US$1.00 per gallon.
Host Analytics is a provider of on-demand corporate and financial performance management solutions. Host Analytic's solutions help financial, line of business and departmental executives improve their budgeting, forecasting, financial consolidations, dashboarding, scorecarding, reporting and analysis. Host Analytics delivers its suite of corporate performance manageme...
More >>
Host Analytics is a provider of on-demand corporate and financial performance management solutions. Host Analytic's solutions help financial, line of business and departmental executives improve their budgeting, forecasting, financial consolidations, dashboarding, scorecarding, reporting and analysis. Host Analytics delivers its suite of corporate performance management solutions via the Software as a Service (SaaS) model.
<< Less
Gynesonics, Inc. is a development stage company focusing on medical devices for women's health, including a novel approach for treating uterine fibroids. Gynesonics VizAblate system permits the gynecologist to diagnose, target and treat multiple fibroid tumors simultaneously and aims to provide significant advantages over existing invasive procedures as well as other ...
More >>
Gynesonics, Inc. is a development stage company focusing on medical devices for women's health, including a novel approach for treating uterine fibroids. Gynesonics VizAblate system permits the gynecologist to diagnose, target and treat multiple fibroid tumors simultaneously and aims to provide significant advantages over existing invasive procedures as well as other minimally invasive techniques being developed.
<< Less
Zeltiq Aesthetics, founded in 2005, is a science-based medical device company dedicated to the development and commercialization of non-invasive procedures to help patients achieve cosmetic improvements by reducing or modifying unwanted fat. The Zeltiq approach utilizes a novel technology called cryolipolysis (the use of controlled cooling to remove fat). Zeltiq Aesth...
More >>
Zeltiq Aesthetics, founded in 2005, is a science-based medical device company dedicated to the development and commercialization of non-invasive procedures to help patients achieve cosmetic improvements by reducing or modifying unwanted fat. The Zeltiq approach utilizes a novel technology called cryolipolysis (the use of controlled cooling to remove fat). Zeltiq Aesthetics has licensed all commercial development rights from Massachusetts General Hospital and is continuing evaluation and development with leading aesthetic research centers.
<< Less
This page is accessible to a membership level higher than you. To improve your membership level you can try the following:
Review More Companies
Complete your profile
Improve your fanbase
Add/Edit more companies
Send a request to site admin at membership@chubbybrain.com requesting to upgrade your membership level. If your profile is eligible, your membership level will be upgraded and you will be notified.
Why can I not access this page?
This page is accessible to a membership level higher than you. To improve your membership level you can try the following:
Review More Companies
Complete your profile
Improve your fanbase
Add/Edit more companies
Send a request to site admin at membership@chubbybrain.com requesting to upgrade your membership level. If your profile is eligible, your membership level will be upgraded and you will be notified.
9,817 Investors 
